HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PD 180970

inhibits p210(Bcr-Abl) tyrosine kinase; structure in first source
Also Known As:
6-(2,6-Dichlorophenyl)-2-((4-fluoro-3-methylphenyl)amino)-8-methylpyrido(2,3-d)pyrimidin-7(8H)-one; PD-180970; PD180970; Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-(2,6-dichlorophenyl)-2-((4-fluoro-3-methylphenyl)amino)-8-methyl-
Networked: 5 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jove, Richard: 2 articles (07/2003 - 10/2002)
2. Bolt, Michael: 1 article (01/2017)
3. Mancini, Maureen G: 1 article (01/2017)
4. Mancini, Michael A: 1 article (01/2017)
5. Marcelli, Marco: 1 article (01/2017)
6. Stephan, Cliff: 1 article (01/2017)
7. Szafran, Adam T: 1 article (01/2017)
8. Haura, Eric B: 1 article (07/2003)
9. Karras, James G: 1 article (07/2003)
10. Song, Lanxi: 1 article (07/2003)

Related Diseases

1. Leukemia
2. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
3. Prostatic Neoplasms (Prostate Cancer)
4. Lung Neoplasms (Lung Cancer)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. tanespimycin (17AAG)
2. src-Family Kinases
3. Phosphotransferases (Kinase)
4. Imatinib Mesylate (Gleevec)
5. Protein-Tyrosine Kinases (Tyrosine Kinase)
6. Ligands
7. Androgens
8. SU 6656
9. bicalutamide (Casodex)

Related Therapies and Procedures

1. Therapeutics